Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hemarus Therapeutics
Hyderabad, Telangana, India
- Ownership
- Private
- Development stage
- Other
01
Overview
Hemarus Therapeutics operates an FDA-approvable cGMP plasma fractionation facility in Hyderabad for producing plasma-derived biologics, serving major unmet needs in India and globally for high-quality plasma derivatives used in hemophilia, immunoglobulin therapies, and critical care[3][5][9].
- Therapeutic areas
- ImmunologyGastroenterologyRare DiseasesHematologyOtherDermatology
- Modalities
- BiologicPlasma-derived therapy
- Industry
- Biotech
02
Partnerships
Diagnostic and R&D companies (open to collaboration)[1][3]No major pharma partnerships publicly disclosed
Beyond the preview
Go deeper on Hemarus Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hemarus Therapeutics.